The Richter Group manufactures more than 200 drugs, and its products include original, generic and licensed products which provide effective, modern and reasonably priced treatments in almost every therapeutic area. The company focuses on developing and manufacturing central nervous system, cardiovascular and women's healthcare products.
In Australia, Gedeon Richter is proud of its growing Women's Health & Osteoporosis portfolios.
Helping hand for infertile families
We aim to support women and families to be what they want to be by growing their families or preserving their fertility.
Our Fertility Portfolio includes:
AFOLIATM (r-hFSH for privately-paying patients) Product Information
BEMFOLA® (r-hFSH alfa) Product Information
CYCLOGEST® (progesterone) Product Information
Real support for healthier bones
We aim to support sufferers of osteoporosis to be who they want to be.
Our Osteoporosis Portfolio includes:
TERROSA® (teriparatide) Product Information
Novel treatment options for women
Ongoing innovation in women's health is essential. Gedeon Richter continues to develop and bring to market innovative treatments for women and those assigned female at birth.
Our Gynaecology Portfolio includes:
RYEQO® (relugolix, estradiol, and norethisterone acetate) Product Information
